• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » PDR, LDM Group merge

PDR, LDM Group merge

November 5, 2014
CenterWatch Staff

PDR Network, a Montvale, N.J.-based provider of drug information and prescriber communications, has merged with LDM Group, a St. Louis, Mo.-based provider of behavior-based patient and consumer health information.  

Thomas H. Lee, president of Lee Equity Partners, the majority shareholder of PDR, said, “This merger brings together two companies known for high-quality health information. PDR, trusted by generations of healthcare providers to deliver important drug information, and LDM, with its unmatched offering of behavior-based patient and consumer health information, now will offer innovative ways to create value for EHR/EMR partners, pharmacies, payers and pharmaceutical manufacturers with services that enable prescribers and their patients to achieve better health.”    

“The realities of the new healthcare delivery models require all participants to have access to more timely and relevant health information,” said Mark Heinold, CEO of the new company. “We believe that when it comes to healthcare, knowledge really is power—and in the hands of healthcare professionals and patients, it can significantly impact health outcomes.”  

PDR’s expanded ability to deliver health information will include the broadest EHR reach—deep into prescriber workflow—when and where prescribing decisions are made. This capability, combined with a proven ability to reinforce provider-patient communications through pharmacist-led counseling, significantly improves medication adherence and patient outcomes.  

In addition, PDR will offer digital communications channels designed to reach healthcare providers outside of workflow, with PDR-delivered education and clinical messages received by physicians, nurse practitioners, physicians’ assistants and pharmacists.

In conjunction with this transaction, Richard Altus, PDR’s former president and CEO, will be joining Lee Equity as an operating advisor. In this role, he will participate actively in evaluating new investment opportunities.       

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing